Media coverage about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Novadaq Technologies earned a news impact score of 0.20 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 44.4407447982075 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
A number of research firms have issued reports on NVDQ. Scotiabank cut their price target on Novadaq Technologies from $15.50 to $13.25 and set an “outperform” rating for the company in a research note on Tuesday, June 20th. Canaccord Genuity downgraded Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 price target for the company. in a research note on Monday, July 10th. Stifel Nicolaus restated a “buy” rating and set a $10.00 price target on shares of Novadaq Technologies in a research note on Friday, June 2nd. Zacks Investment Research upgraded Novadaq Technologies from a “sell” rating to a “hold” rating in a research note on Friday, August 18th. Finally, Northland Securities restated a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $11.86.
Novadaq Technologies (NASDAQ NVDQ) opened at 11.75 on Tuesday. The company’s 50 day moving average price is $11.68 and its 200-day moving average price is $9.03. Novadaq Technologies has a 52 week low of $5.84 and a 52 week high of $12.74. The company’s market capitalization is $679.41 million.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Novadaq Technologies (NVDQ) Share Price” was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.themarketsdaily.com/2017/09/12/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-novadaq-technologies-nvdq-share-price.html.
About Novadaq Technologies
NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.